Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diseases of the Thyroid

Free Subscription Articles published in Endocr J Retrieve available abstracts of 56 articles: HTML format

Single Articles

September 2025
1. HIROSE R, Noh JY, Watanabe N, Yoshihara A, et al
   Thyroid volume reduction in patients with thyroid stimulation-blocking antibody who transitioned from Graves' hyperthyroidism to hypothyroidism: a single-center retrospective study.
   Endocr J. 2025 Sep 27. doi: 10.1507/endocrj.EJ25-0274.
   PubMed     Abstract available
   
   
   
2. NAKASHIMA Y, Horie I, Arimori H, Ueda M, et al
   Real-world clinical experience of reduced-dose initiation of lenvatinib in Japanese patients with radioiodine-refractory differentiated thyroid cancer.
   Endocr J. 2025 Sep 4. doi: 10.1507/endocrj.EJ25-0251.
   PubMed     Abstract available
   
   
   July 2025
3. SAILAUBEKOVA Y, Matsuda K, Akazawa Y, Kurohama H, et al
   Altered expression of autophagy-related molecules and beta-catenin in different subtypes of thyroid cancer: co-localization in intranuclear cytoplasmic inclusions.
   Endocr J. 2025 Jul 17. doi: 10.1507/endocrj.EJ25-0181.
   PubMed     Abstract available
   
   
   
4. SATO M, Kubota R, Uchino S, Morita T, et al
   p.M918W, a novel RET germline variant: a case report and literature review of the possible association of multiple endocrine neoplasia type 2B and Charcot-Marie-Tooth disease.
   Endocr J. 2025;72:839-845.
   PubMed     Abstract available
   
   
   June 2025
5. NAGAYAMA Y, Tajiri J, Murakami T, Watanabe N, et al
   A questionnaire survey of thyroid specialists in Japan on the use of thyroid hormones in hypothyroid and euthyroid patients.
   Endocr J. 2025 Jun 10. doi: 10.1507/endocrj.EJ25-0106.
   PubMed     Abstract available
   
   
   
6. AMANO I, Ninomiya A, Koibuchi N
   Neurological consequences of adult-onset hypothyroidism.
   Endocr J. 2025 Jun 4. doi: 10.1507/endocrj.EJ25-0163.
   PubMed     Abstract available
   
   
   
7. MURAKAMI T, Higaki N, Nishijima Y, Tani J, et al
   Goiter index: an easily available ultrasonographic index for thyroid volume in autoimmune thyroid diseases.
   Endocr J. 2025 Jun 3. doi: 10.1507/endocrj.EJ25-0070.
   PubMed     Abstract available
   
   
   May 2025
8. AMANO I, Ninomiya A, Yajima H, Suda-Yajima M, et al
   Effects of excessive iodine intake during the perinatal period on thyroid function and higher brain functions in mouse offspring.
   Endocr J. 2025 May 28. doi: 10.1507/endocrj.EJ24-0723.
   PubMed     Abstract available
   
   
   
9. HOSODA A, Arata N, Umehara N, Sato S, et al
   Prediction of fetal Graves' disease among pregnant women with Graves' disease who have undergone thyroidectomy or radioactive iodine therapy: A retrospective observational study.
   Endocr J. 2025 May 17. doi: 10.1507/endocrj.EJ24-0434.
   PubMed     Abstract available
   
   
   April 2025
10. NOH JY, Watanabe N, Ito K, Tsuiki M, et al
    Safety, pharmacokinetics, and potential benefits of TSH-receptor-specific monoclonal autoantibody K1-70(TM) in Japanese Graves' disease patients: results of a phase 1 trial.
    Endocr J. 2025 Apr 29. doi: 10.1507/endocrj.EJ25-0043.
    PubMed     Abstract available
    
    
    
11. HONG-QUN W, Ya-Qi M, Ying L, Huai-Yin S, et al
    Clinicopathological features of follicular thyroid carcinoma coexisting with papillary thyroid carcinoma.
    Endocr J. 2025 Apr 24. doi: 10.1507/endocrj.EJ24-0523.
    PubMed     Abstract available
    
    
    March 2025
12. NAGAYAMA Y, Tachibana S, Fukuda T, Katsuyama K, et al
    Early postoperative levothyroxine initiation after total thyroidectomy for Graves' disease.
    Endocr J. 2025 Mar 27. doi: 10.1507/endocrj.EJ25-0009.
    PubMed     Abstract available
    
    
    
13. HOSHIYAMA A, Hayashi A, Taguchi T, Ohata Y, et al
    Disseminated intravascular coagulation as a frequent and critical complication of thyroid storm: a single-center retrospective survey.
    Endocr J. 2025 Mar 22. doi: 10.1507/endocrj.EJ24-0542.
    PubMed     Abstract available
    
    
    
14. ITO Y, Yamamoto M, Kihara M, Onoda N, et al
    Establishment of novel prognostic groups for papillary thyroid carcinoma using a modified risk classification based on tumor extension in the guidelines of the Japan Association of Endocrine Surgery.
    Endocr J. 2025 Mar 8. doi: 10.1507/endocrj.EJ24-0610.
    PubMed     Abstract available
    
    
    
15. SUGITANI I, Kiyota N, Ito Y, Onoda N, et al
    The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery.
    Endocr J. 2025 Mar 8. doi: 10.1507/endocrj.EJ24-0644.
    PubMed     Abstract available
    
    
    February 2025
16. NISHIJIMA Y, Murakami T, Higaki N, Tani J, et al
    The prognosis of severe subclinical hyperthyroidism with TSH below 0.1 muU/mL due to Graves' disease in the Japanese population.
    Endocr J. 2025 Feb 26. doi: 10.1507/endocrj.EJ24-0424.
    PubMed     Abstract available
    
    
    
17. TAKIZAWA H, Uchida T, Suzuki N, Onose H, et al
    Influence of therapeutic inorganic iodine on long-term prognosis of Graves' disease: a multicenter prospective observational study.
    Endocr J. 2025 Feb 22. doi: 10.1507/endocrj.EJ24-0575.
    PubMed     Abstract available
    
    
    
18. ITO Y, Sakumoto J, Hirabayashi H, Haruna S, et al
    Assessing the potential of high-mobility group AT-hook 2 immunohistochemical staining as a prognostic marker of metastatic recurrence in follicular thyroid cancer: a retrospective cohort study.
    Endocr J. 2025 Feb 19. doi: 10.1507/endocrj.EJ24-0557.
    PubMed     Abstract available
    
    
    
19. HATAYA Y, Fujishima Y, Fujimoto K, Iwakura T, et al
    Association between serum thyroglobulin levels and glycemic control in patients with thyroid cancer after radioiodine therapy.
    Endocr J. 2025 Feb 1. doi: 10.1507/endocrj.EJ24-0417.
    PubMed     Abstract available
    
    
    
20. SHIBATA Y, Oiwa A, Tanaka H, Kubota S, et al
    Characteristics of patients with Graves' disease who developed drug resistance and required surgery.
    Endocr J. 2025 Feb 1. doi: 10.1507/endocrj.EJ24-0494.
    PubMed     Abstract available
    
    
    January 2025
21. YOSHIHARA A, Noh JY, Inoue K, Koshibu M, et al
    Long-term outcomes after a radioactive iodine treatment for a single autonomous functioning thyroid nodule in Japan.
    Endocr J. 2025 Jan 23. doi: 10.1507/endocrj.EJ24-0578.
    PubMed     Abstract available
    
    
    December 2024
22. NGUYEN VPT, Kurohama H, Akazawa Y, Nguyen TNA, et al
    Clinicopathological and molecular characteristics of papillary thyroid carcinoma in adolescent and young adult patients.
    Endocr J. 2024 Dec 3. doi: 10.1507/endocrj.EJ24-0504.
    PubMed     Abstract available
    
    
    October 2024
23. ITO Y, Kawakami M, Hirokawa M, Yamamoto M, et al
    Management of thyroid tumors diagnosed cytologically as follicular neoplasms in a high-volume center: utility of a scoring system using serum thyroglobulin level, tumor size, ultrasound testing, and cytological diagnosis.
    Endocr J. 2024 Oct 29. doi: 10.1507/endocrj.EJ24-0364.
    PubMed     Abstract available
    
    
    
24. ITO M, Deguchi-Horiuchi H, Takahashi S, Hisakado M, et al
    Current status of the thyroid hormone measurement items in patients receiving levothyroxine monotherapy by the management based on the thyroid tissue volume.
    Endocr J. 2024 Oct 23. doi: 10.1507/endocrj.EJ24-0259.
    PubMed     Abstract available
    
    
    
25. SUZUKI N, Yoshimura Noh J, Kozaki A, Watanabe N, et al
    Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves' disease.
    Endocr J. 2024 Oct 23. doi: 10.1507/endocrj.EJ24-0401.
    PubMed     Abstract available
    
    
    
26. INAISHI T, Takeuchi D, Ichikawa T, Inaguma G, et al
    Impact of periodic neck ultrasonography on locoregional disease control in surveillance after total thyroidectomy for patients with low- and intermediate-risk papillary thyroid carcinoma: a propensity score-matched study.
    Endocr J. 2024 Oct 1. doi: 10.1507/endocrj.EJ24-0194.
    PubMed     Abstract available
    
    
    September 2024
27. MIZUOCHI K, Hiromatsu Y, Nakamura Y, Sonezaki A, et al
    Transition from hypothyroidism to Graves' disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration of outpatient pulse therapy: a case report with review of literature.
    Endocr J. 2024 Sep 25. doi: 10.1507/endocrj.EJ24-0347.
    PubMed     Abstract available
    
    
    
28. TAZAKI R, Kobashi Y, Nakahata N, Asano M, et al
    Potential implications of thyroid autoantibodies in children, adolescents, and young adults with thyroid nodules in Japan: The Fukushima Health Management Survey.
    Endocr J. 2024 Sep 20. doi: 10.1507/endocrj.EJ24-0293.
    PubMed     Abstract available
    
    
    
29. WATANABE N
    A narrative review of long-term inorganic iodine monotherapy for Graves' disease with a historical relationship between iodine and thyroid.
    Endocr J. 2024 Sep 5. doi: 10.1507/endocrj.EJ24-0186.
    PubMed     Abstract available
    
    
    
30. YOON Y, Park HY, Chae MK, Jang SY, et al
    Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves' orbitopathy.
    Endocr J. 2024;71:851-861.
    PubMed     Abstract available
    
    
    June 2024
31. MANAKA K, Sato J, Hikima Y, Horikoshi H, et al
    Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study.
    Endocr J. 2024 Jun 5. doi: 10.1507/endocrj.EJ23-0699.
    PubMed     Abstract available
    
    
    May 2024
32. YOSHIMURA NOH J, Inoue K, Suzuki N, Yoshihara A, et al
    Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil.
    Endocr J. 2024 May 3. doi: 10.1507/endocrj.EJ24-0135.
    PubMed     Abstract available
    
    
    April 2024
33. YAMAGAMI A, Iwama S, Kobayashi T, Zhou X, et al
    Changes in TgAb and TPOAb titers are greater in thyrotoxicosis than isolated hypothyroidism induced by PD-1 blockade.
    Endocr J. 2024 Apr 11. doi: 10.1507/endocrj.EJ23-0480.
    PubMed     Abstract available
    
    
    
34. MURAKAMI T, Higaki N, Nishijima Y, Tani J, et al
    An easy approach to ultrasonographic volumetry of the thyroid.
    Endocr J. 2024 Apr 11. doi: 10.1507/endocrj.EJ23-0606.
    PubMed     Abstract available
    
    
    March 2024
35. SHIBATA N, Numakura C, Hamajima T, Miyako K, et al
    Clinical and molecular analyses of isolated central congenital hypothyroidism based on a survey conducted in Japan.
    Endocr J. 2024 Mar 8. doi: 10.1507/endocrj.EJ23-0391.
    PubMed     Abstract available
    
    
    February 2024
36. NAKAHATA N, Asano M, Abe N, Ejiri H, et al
    Prevalence of thyroid diffuse goiter and its association with body mass index and the presence of cysts and nodules in children and adolescents: the Fukushima Health Management Survey.
    Endocr J. 2024 Feb 16. doi: 10.1507/endocrj.EJ23-0609.
    PubMed     Abstract available
    
    
    January 2024
37. FUKUDA N, Toda K, Suto H, Oki R, et al
    Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
    Endocr J. 2024 Jan 31. doi: 10.1507/endocrj.EJ23-0378.
    PubMed     Abstract available
    
    
    
38. DEGUCHI-HORIUCHI H, Ito M, Takahashi S, Kousaka K, et al
    Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies.
    Endocr J. 2024 Jan 31. doi: 10.1507/endocrj.EJ23-0497.
    PubMed     Abstract available
    
    
    
39. OMI Y, Yanagida J, Yoshida Y, Horiuchi K, et al
    Risk factors for mediastinal lymph node metastasis and lung metastasis in papillary thyroid carcinoma patients: who benefits from preoperative computed tomography?
    Endocr J. 2024 Jan 19. doi: 10.1507/endocrj.EJ23-0413.
    PubMed     Abstract available
    
    
    December 2023
40. TODA S, Iwasaki H, Okubo Y, Hayashi H, et al
    The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
    Endocr J. 2023 Dec 1. doi: 10.1507/endocrj.EJ23-0342.
    PubMed     Abstract available
    
    
    November 2023
41. KOBAYASHI T, Iwama S, Arima H
    Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events.
    Endocr J. 2023 Nov 7. doi: 10.1507/endocrj.EJ23-0524.
    PubMed     Abstract available
    
    
    October 2023
42. MO C, Zhong L
    The effect of acromegaly on thyroid disease.
    Endocr J. 2023 Oct 25. doi: 10.1507/endocrj.EJ23-0356.
    PubMed     Abstract available
    
    
    
43. ITO Y, Miyauchi A, Fujishima M, Yamamoto M, et al
    Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital.
    Endocr J. 2023 Oct 4. doi: 10.1507/endocrj.EJ23-0395.
    PubMed     Abstract available
    
    
    September 2023
44. HAGA E, Inoue N, Iwatani Y, Arakawa Y, et al
    Intraindividual variation in histone acetylation and its impact on autoimmune thyroid diseases.
    Endocr J. 2023 Sep 30. doi: 10.1507/endocrj.EJ23-0204.
    PubMed     Abstract available
    
    
    
45. KAWAMOTO T, Yasuda K, Ito Y, Zenda S, et al
    Adjuvant treatments for locally advanced differentiated thyroid cancer: a nationwide survey in Japan.
    Endocr J. 2023 Sep 30. doi: 10.1507/endocrj.EJ23-0330.
    PubMed     Abstract available
    
    
    
46. WATANABE N, Yoshimura Noh J, Kozaki A, Yoshimura R, et al
    Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal
    Endocr J. 2023 Sep 22. doi: 10.1507/endocrj.EJ23-0079.
    PubMed     Abstract available
    
    
    
47. ARIMITSU H, Nishijima Y, Higaki N, Noguchi H, et al
    A case report of anaplastic thyroid carcinoma transformed from small papillary carcinoma successfully detected by ultrasonography in its early stage with review of literature.
    Endocr J. 2023 Sep 16. doi: 10.1507/endocrj.EJ23-0197.
    PubMed     Abstract available
    
    
    
48. DEANDREA M, Piticchio T, Mormile A, Retta F, et al
    Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
    Endocr J. 2023 Sep 9. doi: 10.1507/endocrj.EJ23-0273.
    PubMed     Abstract available
    
    
    August 2023
49. YAMAUCHI I, Hakata T, Sugawa T, Kosugi D, et al
    Prediction-based prompt levothyroxine replacement to prevent a hypothyroid state after immune-related adverse events involving the thyroid gland.
    Endocr J. 2023 Aug 11. doi: 10.1507/endocrj.EJ23-0262.
    PubMed     Abstract available
    
    
    
50. MATSUSE M, Mitsutake N
    TERT promoter mutations in thyroid cancer.
    Endocr J. 2023 Aug 1. doi: 10.1507/endocrj.EJ23-0136.
    PubMed     Abstract available
    
    
    June 2023
51. FUJISHIMA M, Miyauchi A, Ito Y, Sasaki T, et al
    Outcomes of immediate surgery for low-risk papillary thyroid microcarcinoma in patients with or without risky features at surgery.
    Endocr J. 2023 Jun 28. doi: 10.1507/endocrj.EJ23-0107.
    PubMed     Abstract available
    
    
    
52. SHIMMARU K, Inami M, Hamaoka A, Fujiwara N, et al
    Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report.
    Endocr J. 2023 Jun 17. doi: 10.1507/endocrj.EJ23-0062.
    PubMed     Abstract available
    
    
    May 2023
53. TERASHIMA R, Tani T, Sakakibara K, Kurusu S, et al
    Thyrotropin-releasing hormone stimulates NR4A3 expression in the pituitary thyrotrophs of proestrus rats.
    Endocr J. 2023 May 19. doi: 10.1507/endocrj.EJ23-0080.
    PubMed     Abstract available
    
    
    April 2023
54. SHI W, Song D, Chen D, Duan W, et al
    The association of thyroid parameters with markers of chronic kidney disease in euthyroid patients with type 2 diabetes.
    Endocr J. 2023 Apr 21. doi: 10.1507/endocrj.EJ22-0643.
    PubMed     Abstract available
    
    
    March 2023
55. NAGATA K, Hayashi K, Kumata K, Satoh Y, et al
    Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.
    Endocr J. 2023 Mar 10. doi: 10.1507/endocrj.EJ22-0609.
    PubMed     Abstract available
    
    
    February 2023
56. MIKURA K, Yoshimura Noh J, Watanabe N, Aida A, et al
    Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease.
    Endocr J. 2023 Feb 25. doi: 10.1507/endocrj.EJ22-0505.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.